Dr. Aragones is an internal medicine physician and public health researcher whose areas of expertise include working with primary care provider to address barriers for cancer screening and prevention among minority and immigrant populations, specifically among the Latino population. His primary research interests include understanding primary care providers’ barriers for recommending cancer screening and prevention, designing and implementing interventions tailored to primary care settings and adapted to diverse patient populations, and working with providers in the community serving large Latino populations to design new methods to implement evidence-based interventions into their practice settings.
Dr. Aragones is currently working in the areas of HPV vaccine practices among providers serving large minority populations; developing an intervention to promote the utilization of the HPV vaccine among children of Latino immigrants; and investigating a new model to disseminate and implement evidence-based practices to community physicians serving large Latino populations.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Abraham Aragones discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.